Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to 1.03.

  • TriSalus Life Sciences' Asset Utilization Ratio rose 1516.26% to 1.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.03, marking a year-over-year increase of 1516.26%. This contributed to the annual value of 1.21 for FY2024, which is 5252.35% up from last year.
  • As of Q3 2025, TriSalus Life Sciences' Asset Utilization Ratio stood at 1.03, which was up 1516.26% from 1.03 recorded in Q2 2025.
  • TriSalus Life Sciences' 5-year Asset Utilization Ratio high stood at 1.22 for Q1 2025, and its period low was 0.05 during Q4 2022.
  • Its 4-year average for Asset Utilization Ratio is 0.84, with a median of 0.94 in 2023.
  • As far as peak fluctuations go, TriSalus Life Sciences' Asset Utilization Ratio skyrocketed by 111693.67% in 2023, and later skyrocketed by 468.21% in 2025.
  • Over the past 4 years, TriSalus Life Sciences' Asset Utilization Ratio (Quarter) stood at 0.05 in 2022, then skyrocketed by 1116.94% to 0.64 in 2023, then soared by 79.72% to 1.14 in 2024, then fell by 9.64% to 1.03 in 2025.
  • Its last three reported values are 1.03 in Q3 2025, 1.03 for Q2 2025, and 1.22 during Q1 2025.